Pacer Advisors
FOLD

Pacer Advisors’s Amicus Therapeutics FOLD Stock Holding History

Pacer Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,597
Closed -$25.8K – 2610
2024
Q2 		$25.8K Sell
2,597
-871
-25% -$8.94K ﹤0.01% 3379
2024
Q1 		$40.9K Buy
+3,468
New +$44.4K ﹤0.01% 3253
2021
Q2 		– Sell
-7,238
Closed -$72K – 1458
2021
Q1 		$72K Buy
7,238
+1,252
+21% +$19.4K ﹤0.01% 1362
2020
Q4 		$138K Sell
5,986
-3,632
-38% -$74.3K ﹤0.01% 1301
2020
Q3 		$136K Buy
+9,618
New +$140K ﹤0.01% 1222
2018
Q4 		– Sell
-20,810
Closed -$252K – 731
2018
Q3 		$252K Buy
+20,810
New +$291K 0.01% 982
2018
Q1 		– Sell
-7,500
Closed -$108K – 1071
2017
Q4 		$108K Buy
+7,500
New +$103K 0.01% 954

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Pacer Advisors's FOLD Position: Q3 2024 in Review

Pacer Advisors sold out of Amicus Therapeutics (FOLD) in Q3 2024, closing a stake of 2,597 shares — an estimated $25.8K sold.

Pacer Advisors first reported a position in FOLD in Q4 2017 and held it in 7 quarters. The position peaked at $252K in Q3 2018. 293 funds tracked by Wall St. Rank hold FOLD as of Q3 2024.

  • Pacer Advisors reported no remaining Amicus Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Pacer Advisors sold 2,597 Amicus Therapeutics shares in Q3 2024, an estimated $25.8K.
  • Pacer Advisors first reported a position in Amicus Therapeutics in Q4 2017 and held it in 7 quarters.
  • Pacer Advisors's Amicus Therapeutics position peaked at $252K in Q3 2018.
  • 293 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.